Meeder Asset Management Inc Liquidia Corp Transaction History

Meeder Asset Management Inc

  • $1.42 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020
SELL
$4.86 - $11.44 $4,534 - $10,673
-933 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$3.31 - $7.15 $244 - $529
-74 Reduced 7.35%
933 $4,000
Q4 2019

Feb 13, 2020
SELL
$3.07 - $5.11 $365 - $608
-119 Reduced 10.57%
1,007 $4,000
Q3 2019

Oct 17, 2019
BUY
$3.29 - $8.24 $3,704 - $9,278
1,126 New
1,126 $4,000

Others Institutions Holding LQDA

# of Institutions
162
Shares Held
36M
Call Options Held
1.79M
Put Options Held
380K
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email